Welcome to our dedicated page for Freshpet SEC filings (Ticker: FRPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Freshpet, Inc. (FRPT) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI support to help interpret the information. As a Nasdaq-listed manufacturer of fresh, refrigerated pet foods and treats, Freshpet files annual reports on Form 10-K and quarterly reports on Form 10-Q that describe its business, risk factors, financial statements and management’s discussion and analysis. These core filings provide detail on net sales, gross profit, net income, cash flows, capital expenditures and balance sheet items.
Freshpet also submits current reports on Form 8-K to disclose material events. Recent 8-K filings have covered quarterly financial results, publication of investor presentations, outcomes of the annual meeting of stockholders, executive leadership changes in the finance organization and retention equity awards for key executives. These documents give insight into how the board and its committees address executive compensation, retention and governance matters, as well as how the company communicates financial performance to the market.
On this page, users can track non-GAAP metrics and reconciliations that Freshpet highlights in its earnings materials, such as Adjusted Gross Profit, Adjusted Gross Margin, Adjusted SG&A, EBITDA and Adjusted EBITDA. The company explains how these measures are calculated and why management considers them useful for understanding ongoing operating results.
Stock Titan enhances access to these filings by providing real-time updates from EDGAR and AI-powered summaries that highlight key points in lengthy documents. Investors can quickly locate quarterly and annual reports, 8-Ks about earnings releases and governance events, and other disclosures relevant to Freshpet’s financial condition and corporate oversight.
Freshpet, Inc. president Scott James Morris reported a tax-related share disposition involving 1,574 shares of common stock. On January 3, 2026, 1,574 shares were disposed of at $60.15 per share under transaction code “F,” which reflects shares withheld to cover taxes on the vesting of 4,619 restricted stock units granted on January 3, 2025, representing one-third of a 13,858-unit award. After this transaction, he beneficially owns 194,538 shares directly. This direct position consists of 9,239 restricted stock units from the 2025 award, 5,192 additional restricted stock units that vest in three equal annual installments beginning on March 15, 2026, and 180,107 shares of common stock. He also indirectly holds 30,858 shares of common stock through the Scott Morris 2020 Family Trust.
Freshpet, Inc. approved a 2025 retention equity grant for its Chief Operating Officer, Nicola Baty. The grant has a total Grant Date value of $1,750,819.72 and consists of 13,858 time-based RSUs and 13,858 performance-based RSUs issued under the 2024 Equity Incentive Plan.
The time-based RSUs vest in two equal annual installments beginning January 3, 2027, subject to continued employment. The performance-based RSUs vest, if at all, based 50% on three-year (FY 2025-2027) cumulative net sales and 50% on three-year Adjusted EBITDA margin, with 80% of target vesting at threshold and 120% at maximum for each goal and no vesting if thresholds are not met. The awards feature 100% double-trigger accelerated vesting upon a qualifying termination after a change in control, with no special retirement vesting, while Ms. Baty remains eligible for other annual incentive plans.
Freshpet, Inc. (FRPT) filed a Form 4 for its President detailing option exercises and related share sales on 11/06/2025. The insider exercised options for 35,868 shares at $8.90, 80,214 shares at $11.00, and 1,735 shares at $11.00. Shares were then sold in three trades: 16,822 at $55.19, 45,331 at a weighted average price of $55.21 (within a $54.92–$55.46 range), and 982 at $55.36.
According to the footnotes, certain shares were disposed to cover the option exercise price and applicable withholding taxes, and the options exercised were fully vested under the 2014 Omnibus Incentive Plan. Following these transactions, the insider directly beneficially owned 196,112 shares.
Freshpet, Inc. reported stronger Q3 results. Net sales rose to $288.8 million from $253.4 million, and income from operations increased to $24.9 million from $11.9 million as manufacturing scale and cost controls supported higher gross profit.
Net income jumped to $101.7 million from $11.9 million, primarily due to a $77.9 million deferred tax benefit from releasing a valuation allowance, reflecting sustained profitability and expected utilization of tax attributes. Diluted EPS was $1.86 versus $0.24. For the nine months, sales reached $816.8 million and net income was $105.3 million.
Cash and equivalents were $274.6 million, with $396.8 million of 3.00% convertible senior notes due 2028 (fair value $450.1 million). The company recognized a $12.1 million provision for accounts receivable during the nine-month period, largely tied to a pet specialty distributor liquidation. A distributor dispute was settled on September 15, 2025. Shares outstanding were 48,808,337 as of October 30, 2025.
Freshpet (FRPT) announced it issued a press release with financial results for the quarter ended September 30, 2025, and scheduled a conference call at 8:00 a.m. Eastern Time on November 3, 2025 to discuss the results. The company noted that the press release includes non-GAAP financial measures with reconciliations to comparable GAAP metrics.
Freshpet also posted an investor presentation to its website and stated that it uses the Investors section (investors.freshpet.com) for Regulation FD disclosures. The materials furnished under Items 2.02 and 7.01 are not deemed filed.
Freshpet (FRPT) reported an insider equity award to its interim CFO. On 10/17/2025, the officer received 3,000 restricted stock units (RSUs) of Common Stock at $0 per unit. Following the award, the officer beneficially owns 9,527 shares, held directly.
The RSUs are scheduled to vest in three equal annual installments beginning October 17, 2025, and remain subject to continued service with the company.
Freshpet (FRPT) filed a Form 3 disclosing the interim CFO’s beneficial ownership as of 10/17/2025. The officer reports 6,527 shares of common stock, consisting of 4,855 shares and 1,672 unvested RSUs. RSUs are scheduled to vest as follows: 355 on March 13, 2026; 392 in two equal installments beginning March 15, 2026; and 925 in three equal annual installments beginning March 11, 2026, subject to continued service. The filing also lists options for 27,000 shares at $49.77, fully vested, expiring on 10/01/2029.
Freshpet insider amended Form 4 to correct a clerical error related to restricted stock withholding. The reporting person, the company’s Chief Accounting Officer, had 2,980 shares withheld upon vesting to satisfy tax withholding at a reported price of $68.39 per share. The amendment clarifies the amount of shares beneficially owned following that withholding and replaces the earlier Form 4 disclosure.
Freshpet director George Walter N. reported an open-market purchase of common stock. The Form 4 shows the reporting person acquired 1,000 shares on 09/08/2025 at a weighted average price of $52.57 per share (prices ranged $52.51–$52.60). After the transaction the reporting person beneficially owned 46,527 shares, held directly. The filing was signed by an attorney-in-fact on 09/18/2025. The form discloses only this non-derivative purchase and an explanation that the reported price is a weighted average across multiple executions.
FAQ
What is the current stock price of Freshpet (FRPT)?
What is the market cap of Freshpet (FRPT)?
